Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Genomic and Phenotypic Determinants of Resistance to Immunotherapies in Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
An Open-label, Dose Escalation Study in Japanese Participants With Relapsed/Refractory Multiple Myeloma Who Have Failed Prior Anti Myeloma Treatments
- Status
- COMPLETED
- Phase
- PHASE1
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
- Status
- RECRUITING
- Phase
- PHASE3
A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM)
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
Study to Demonstrate Clinical Benefit of Lenalidomide and Dexamethasone
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
MYeloma Resistance And Clonal Evolution
- Status
- RECRUITING
- Phase
- N/A
64Cu-LLP2A for Imaging Multiple Myeloma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Busulfan, Melphalan, Escalating Carfilzomib Conditioning Auto Stem Cell Transplantation for Multiple Myeloma (MM)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose Therapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Dendritic Cell (DC)/Myeloma Fusions in Combination With Nivolumab in Patients With Relapsed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Detection of Amyloidosis in Multiple Myeloma Patients by [18F]Florbetaben Positron Emission Tomography
- Status
- COMPLETED
- Phase
- NA
Lenalidomide Adherence in Older Adults
- Status
- TERMINATED
- Phase
- N/A
The Myeloma Pack: A Multi-Modality Educational Intervention Strategy to Engage Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2